August 1, 2024

Petoskey man is first in state to receive HEMGENIX gene therapy — 9&10 News

GREEN BAY, WI — Andrew Bartkowiak, a Hemophilia Outreach Center patient from Petoskey, became the first Michigan resident with hemophilia B to receive FDA-approved HEMGENIX gene therapy. His treatment offers new hope for fewer bleeds and freedom from regular infusions.

Read full story on 9&10 News

Recent Posts

The Founding Story of Hemophilia Outreach Center

Caring, Sharing, and Learning TogetherLong before there was a center, a building, or even a formal program, there were two nurses in Green Bay who saw a need and stepped in to meet it. Peggy Maier and Audrey Nuskiewicz were both Registered Nurses working in Pediatrics...

Open Enrollment Is Coming: Help Us Keep Your Care on Track

Open enrollment season is approaching, and now is the time to start preparing for any upcoming changes to your health insurance coverage. For many individuals, Medicare Annual Enrollment runs from October 15 through December 7, while Marketplace (ACA) Open Enrollment...

Help Protect Our Community During Virus Season!

Respiratory illnesses such as influenza, COVID-19, and respiratory syncytial virus (RSV) commonly circulate during the colder months, especially as people are spending more times indoors. Symptoms may include fever, cough, sore throat, runny or stuffy nose, fatigue,...

Building Stronger HTCs for Better Patient Care with Angela Blue

Today on Beyond the Bleeds, Heather and guest co-host Erica are joined by Angela Blue, Director of Member & Community Relations with the Hemophilia Alliance, for a conversation about the important work happening behind the scenes to support Hemophilia Treatment...

Social Media